Chemed Corporation (NYSE: CHE) reported Q4 EPS of $2.10, in-line with the analyst estimate of $2.10. Revenue for the quarter came in at $403 million versus the consensus estimate of $409.89 million.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.